Journal profile
The Lancet Oncology
The Lancet Oncology is published by Elsevier BV under ISSN 1470-2045. It holds an h-index of 524 across 12,121 indexed works, with a two-year mean citedness of 11.99, and is not fully open access. Its main subject areas are Lung Cancer Treatments and Mutations, Global Cancer Incidence and Screening, Economic and Financial Impacts of Cancer.
Below: the full publication record, and one real article from the journal formatted in IEEE, APA, and BibTeX so you can match field order against a source you can check.
Publication record and impact metrics
| Publisher | Elsevier BV |
|---|---|
| ISSN-L | 1470-2045 |
| All ISSNs | 1470-2045, 1474-5488 |
| Indexed works | 12,121 |
| Total citations | 1,067,817 |
| h-index | 524 |
| 2-year mean citedness | 11.99 |
| Open access | Not fully open access |
| Main topics | Lung Cancer Treatments and Mutations · Global Cancer Incidence and Screening · Economic and Financial Impacts of Cancer · Advances in Oncology and Radiotherapy · Cancer Immunotherapy and Biomarkers |
Publication figures come from this journal's OpenAlex record, released under CC0, and are a dated snapshot rather than a live count. Check the publisher for current scope and submission requirements.
A worked example from this journal
The source
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
- Authors
- Roger Stupp, Monika E. Hegi, Warren Mason, Martin J. van den Bent, Martin Taphoorn, Robert C. Janzer, and 18 more
- Year
- 2009
- Volume
- 10
- Issue
- 5
- Pages
- 459-466
IEEE
R. Stupp, M. E. Hegi, W. Mason, M. J. V. D. Bent, M. Taphoorn, R. C. Janzer et al. "Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial," The Lancet Oncology, vol. 10, no. 5, pp. 459-466, 2009, doi: 10.1016/s1470-2045(09)70025-7.
IEEE prints author initials before the surname and abbreviates the periodical title. Check the abbreviation for The Lancet Oncology against your target publication's reference list before submitting.
APA
Stupp, R., Hegi, M. E., Mason, W., Bent, M. J. V. D., Taphoorn, M., & Janzer, R. C., et al. (2009). Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. The Lancet Oncology, 10(5), 459-466. https://doi.org/10.1016/s1470-2045(09)70025-7
APA puts the year directly after the authors, keeps the full journal title in italics, and renders the DOI as a URL.
BibTeX
@article{stupp2009,
author = {Roger Stupp and Monika E. Hegi and Warren Mason and Martin J. van den Bent and Martin Taphoorn and Robert C. Janzer},
title = {Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial},
journal = {The Lancet Oncology},
volume = {10},
number = {5},
pages = {459--466},
year = {2009},
issn = {1470-2045},
doi = {10.1016/s1470-2045(09)70025-7}
}The citation key is the first author's surname and the year. Keep it stable once it appears in a draft, because renaming it breaks every cite that used it.
What to verify before you submit
- The volume and page range. The Lancet Oncology records 12,121 works, and articles published online first can carry a different volume from the final issue. Cite the version you read.
- The abbreviated title. IEEE style uses standard periodical abbreviations, and registry metadata almost always returns the full name instead.
- Author name order. Registry records store full given names; IEEE and APA both want initials, formatted differently from each other.
- Whether the article is open access. This journal is not fully open access, which affects whether a reader can reach the version you cited.
- That the source supports your claim. A correctly formatted reference says nothing about whether the passage backs the sentence citing it.
How this journal sits in the record
The Lancet Oncology carries an h-index of 524, which is above 88% of the journals covered here, and its articles have accumulated 1,067,817 citations across 12,121 indexed works. Its two-year mean citedness is 11.99.
209 of the journals covered here are published by Elsevier BV. Reference style is set per title rather than per publisher, so do not carry a format across from a sibling journal without checking.
These are indexing figures describing how often work in this venue is cited. They say nothing about whether a particular article is sound, and they are not a substitute for reading it.
Questions about The Lancet Oncology
What is the ISSN of The Lancet Oncology?
The linking ISSN is 1470-2045. The journal also carries 1474-5488, which usually separate the print and electronic editions. Use the linking ISSN in a BibTeX issn field.
Who publishes The Lancet Oncology?
Elsevier BV publishes it. 209 journals covered here come from the same publisher, and they do not all share one reference style, so check the requirements for this title rather than the publisher.
Is The Lancet Oncology open access?
OpenAlex does not record it as fully open access. Some articles may still be open individually, so check the specific article rather than assuming from the journal.
How do I cite an article from The Lancet Oncology in LaTeX?
Use the BibTeX entry above as the pattern. The entry type is article, the journal field holds the full title, and the citation key stupp2009 follows the first author's surname and the year. Brace any acronym in the title so your bibliography style does not lowercase it.
Does The Lancet Oncology use page numbers or article numbers?
The example article runs from page 459 to 466, so this journal used page ranges at least for that volume. Newer issues in many journals switched to article numbers, so check the version you are citing.
How influential is The Lancet Oncology?
Its h-index is 524, above 88% of the journals covered here, and its articles have been cited 1,067,817 times in total. Its two-year mean citedness is 11.99. These are indexing figures, not a judgement of whether a specific article is sound.
Does The Lancet Oncology have a Journal Impact Factor?
Not one shown here. The Journal Impact Factor is Clarivate's metric, published in Journal Citation Reports and readable only with a JCR subscription, so this page does not restate it. The figures above come from OpenAlex: an h-index of 524 and a two-year mean citedness of 11.99 across 12,121 indexed works, captured on 2026-09-18. Mean citedness averages citations per work over a two-year window, which makes it closer in construction to CiteScore than to the Impact Factor. The three are not interchangeable, so quote whichever one your target venue actually asks for.